R. Charles (Charlie) Inclan is a Healthcare M&A attorney with Foley & Lardner LLP. Charlie is based in the Dallas office where he is a member of the Health Care Practice Group.
Charlie focuses his practice on various complex transactions including mergers, acquisitions and divestitures, recapitalizations, buyouts, carve-outs, and corporate governance, with a particular focus on healthcare-related transactions.
Prior to joining Foley, Charlie practiced at an international law firm, where he focused on private equity transactions.
Representative Experience
- Represented Ares’s Infrastructure and Power strategy in its $600 million strategic equity investment in SB Energy, SoftBank Group Corp.’s U.S. Climate Infrastructure Technology platform
- Represented Bernhard, an energy-as-a-service solutions company, in connection with a sale to DIF Capital Partners
- Represented Nordic Capital-led consortium in its $7.3 billion acquisition of Inovalon
- Represented ECP in connection with the acquisition of Liberty Tire Recycling from The Carlyle Group
- Represented Bain Capital in the investment in PartsSource
- Represented Envista Holdings Corporation on its definitive agreement to acquire Carestream Dental’s intra-oral scanners business.
- Represented Bernhard, an energy-as-a-service solutions company, in connection with a sale to DIF Capital Partners
- Represented Strathcona Resources Ltd. in its inaugural offering of $500 million of its 6.875% senior notes due 2026
- Represented HealthCor Catalio Acquisition Corp. (Nasdaq: HCAQ), a special purpose acquisition company, in its $580 million combination with Hyperfine, Inc., creator of the first U.S. Food and Drug Administration cleared portable magnetic resonance imaging device, Swoop™, and Liminal Sciences, Inc., a medical device development company dedicated to non-invasive measurement of key vital signs in the brain
- Represented Corner Growth Acquisition Corp. 2, a special purpose acquisition company, in its $185 million initial public offering
- Represented Vector Acquisition Corporation on its $4.1 billion definitive merger agreement with Rocket Lab USA, Inc.
- Represented Power & Digital Infrastructure Acquisition Corp., a blank check company sponsored by XPDI Sponsor LLC, on its upsized $300 million initial public offering
- Represented Talos Production Inc., a wholly owned subsidiary of Talos Energy Inc. (NYSE: TALO), in connection with its upsized add-on offering of $150 million of additional 12.00% Second-Priority Senior Secured Notes due 2026
- Represented Talos Production Inc., a wholly owned subsidiary of Talos Energy Inc. (NYSE: TALO), in connection with its upsized offering of $500 million of its new 12.00% Second-Priority Senior Secured Notes due 2026
- Represented Talos Energy Inc. (NYSE: TALO) in connection with its follow-on offering of 8,250,000 shares of its common stock for gross proceeds of $73 million
- Represented Bluescape Opportunities Acquisition Corp., a special purpose acquisition company that will target businesses in the energy and industrial sectors, in connection with its $575 million initial public offering
Affiliations
- Member, Texas State Bar
- American Health Law Association
Presentations and Publications
- Presenter, “Legal Considerations for Startups,” Startup 101 – A Founder’s Guide to Launching a Startup (2021)
Foley Serves as Lead Counsel to UF Health in Acquisition of Flagler Health+
Foley & Lardner LLP served as lead counsel to UF Health, the University of Florida’s academic health center, in its acquisition of Flagler Health+.
Foley Serves as Legal Adviser to HeartPlace in Recapitalization by US Heart and Vascular
Foley & Lardner LLP served as legal adviser to HeartPlace, the largest physician-owned cardiology group in Texas, in the successful closing of its recapitalization by US Heart and Vascular
Physician Practice Transactions: NY’s Proposed Review and Monitoring Increases Visibility and Adds Deal Risk
New York Governor Kathy Hochul unveiled a proposal, set forth in the Health and Mental Hygiene Article VII Legislation associated with the proposed State Executive Budget for FY2024.